Paraganglioma and phaeochromocytoma: from genetics to personalized medicine.
Favier J, Amar L, Gimenez-Roqueplo AP.
Nat Rev Endocrinol. 2015 Feb;11(2):101-11. doi: 10.1038/nrendo.2014.188. Epub 2014 Nov 11.
Hereditary hormone excess: genes, molecular pathways, and syndromes.
Marx SJ, Simonds WF.
Endocr Rev. 2005 Aug;26(5):615-61. doi: 10.1210/er.2003-0037. Epub 2005 Jan 4.
[Diagnostic problems in pheochromocytoma].
Mannelli M, Pupilli C, Lanzillotti R, Ianni L, Bellini F.
Minerva Endocrinol. 1995 Mar;20(1):55-61.
SDHB-Associated Paraganglioma in a Pediatric Patient and Literature Review on Hereditary Pheochromocytoma-Paraganglioma Syndromes.
Choat H, Derrevere K, Knight L, Brown W, Mack EH.
Case Rep Endocrinol. 2014;2014:502734. doi: 10.1155/2014/502734. Epub 2014 Sep 15.
Metabolome profiling by HRMAS NMR spectroscopy of pheochromocytomas and paragangliomas detects SDH deficiency: clinical and pathophysiological implications.
Imperiale A, Moussallieh FM, Roche P, Battini S, Cicek AE, Sebag F, Brunaud L, Barlier A, Elbayed K, Loundou A, Bachellier P, Goichot B, Stratakis CA, Pacak K, Namer IJ, Taïeb D.
Neoplasia. 2015 Jan;17(1):55-65. doi: 10.1016/j.neo.2014.10.010.
Neuroendocrine secretory protein-55 (NESP-55) expression discriminates pancreatic endocrine tumors and pheochromocytomas from gastrointestinal and pulmonary carcinoids.
Srivastava A, Padilla O, Fischer-Colbrie R, Tischler AS, Dayal Y.
Am J Surg Pathol. 2004 Oct;28(10):1371-8. doi: 10.1097/01.pas.0000135527.96318.20.
Diagnostic value of serum chromogranin-A combined with MIBG scintigraphy inpatients with adrenal incidentalomas.
Giovanella L, Ceriani L, Balerna M, Keller F, Taborelli M, Marone C, Ferone D.
Q J Nucl Med Mol Imaging. 2008 Mar;52(1):84-88.
Identification of three new variants of SDHx genes in a cohort of Portuguese patients with extra-adrenal paragangliomas.
Domingues R, Montalvão P, Magalhães M, Santos R, Duarte L, Bugalho MJ.
J Endocrinol Invest. 2012 Dec;35(11):975-80. doi: 10.3275/8237. Epub 2012 Jan 30.
Absence of mutations in the MEN2A region of the ret proto-oncogene in non-MEN 2A phaeochromocytomas.
Chew SL, Lavender P, Jain A, Weber A, Ross RJ, Wass JA, Besser GM, Clark AJ.
Clin Endocrinol (Oxf). 1995 Jan;42(1):17-21. doi: 10.1111/j.1365-2265.1995.tb02593.x.
